Bionomics Limited B1N0.F Stock
Bionomics Limited Price Chart
Bionomics Limited B1N0.F Financial and Trading Overview
| Bionomics Limited stock price | 0.53 EUR |
| Previous Close | 1.96 EUR |
| Open | 1.92 EUR |
| Bid | 1.92 EUR x N/A |
| Ask | 2.52 EUR x N/A |
| Day's Range | 1.92 - 1.92 EUR |
| 52 Week Range | 1.35 - 9.4 EUR |
| Volume | 70 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 17.69M EUR |
| Beta (5Y Monthly) | 2.256704 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
B1N0.F Valuation Measures
| Enterprise Value | -14090919 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.9394534 |
| Price/Book (mrq) | 0.3333333 |
| Enterprise Value/Revenue | -2.341 |
| Enterprise Value/EBITDA | 0.707 |
Trading Information
Bionomics Limited Stock Price History
| Beta (5Y Monthly) | 2.256704 |
| 52-Week Change | -65.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.4 EUR |
| 52 Week Low | 1.35 EUR |
| 50-Day Moving Average | 1.82 EUR |
| 200-Day Moving Average | 4.59 EUR |
B1N0.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 8.16M |
| Float | 5.44M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 7.76% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -346.16% |
| Gross Margin | -229.036% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.97% |
| Return on Equity (ttm) | -46.13% |
Income Statement
| Revenue (ttm) | 6.02M EUR |
| Revenue Per Share (ttm) | 0.72 EUR |
| Quarterly Revenue Growth (yoy) | -21.60% |
| Gross Profit (ttm) | -9943677 EUR |
| EBITDA | -19929630 EUR |
| Net Income Avi to Common (ttm) | -24913854 EUR |
| Diluted EPS (ttm) | -2.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 30.7M EUR |
| Total Cash Per Share (mrq) | 3.76 EUR |
| Total Debt (mrq) | 614.55K EUR |
| Total Debt/Equity (mrq) | 1.29 EUR |
| Current Ratio (mrq) | 9.053 |
| Book Value Per Share (mrq) | 5.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17925264 EUR |
| Levered Free Cash Flow (ttm) | -6967175 EUR |
Profile of Bionomics Limited
| Country | Germany |
| State | SA |
| City | Eastwood |
| Address | 200 Greenhill Road |
| ZIP | 5063 |
| Phone | 61 8 8150 7400 |
| Website | https://www.bionomics.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
Q&A For Bionomics Limited Stock
What is a current B1N0.F stock price?
Bionomics Limited B1N0.F stock price today per share is 0.53 EUR.
How to purchase Bionomics Limited stock?
You can buy B1N0.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bionomics Limited?
The stock symbol or ticker of Bionomics Limited is B1N0.F.
Which industry does the Bionomics Limited company belong to?
The Bionomics Limited industry is Biotechnology.
How many shares does Bionomics Limited have in circulation?
The max supply of Bionomics Limited shares is 18.34M.
What is Bionomics Limited Price to Earnings Ratio (PE Ratio)?
Bionomics Limited PE Ratio is now.
What was Bionomics Limited earnings per share over the trailing 12 months (TTM)?
Bionomics Limited EPS is -1.9 EUR over the trailing 12 months.
Which sector does the Bionomics Limited company belong to?
The Bionomics Limited sector is Healthcare.